Literature DB >> 21746802

Mapping the differential distribution of glycosaminoglycans in the adult human retina, choroid, and sclera.

Simon J Clark1, Tiarnan D L Keenan, Helen L Fielder, Lisa J Collinson, Rebecca J Holley, Catherine L R Merry, Toin H van Kuppevelt, Anthony J Day, Paul N Bishop.   

Abstract

PURPOSE. To map the distribution of different classes of glycosaminoglycans (GAGs) in the healthy human retina, choroid, and sclera. METHODS. Frozen tissue sections were made from adult human donor eyes. The GAG chains of proteoglycans (PGs) were detected with antibodies directed against various GAG structures (either directly or after pretreatment with GAG-degrading enzymes); hyaluronan (HA) was detected using biotinylated recombinant G1-domain of human versican. The primary detection reagents were identified with FITC-labeled probes and analyzed by fluorescence microscopy. RESULTS. Heparan sulfate (HS), chondroitin sulfate (CS), dermatan sulfate (DS), and HA were present throughout the retina and choroid, but keratan sulfate (KS) was detected only in the sclera. HS labeling was particularly strong in basement membrane-containing structures, the nerve fiber layer (NFL), and retinal pigment epithelium (RPE)-for example, intense staining was seen with an antibody that binds strongly to sequences containing 3-O-sulfation in the internal limiting membrane (ILM) and in the basement membrane of blood vessels. Unsulfated CS was seen throughout the retina, particularly in the ILM and interphotoreceptor matrix (IPM) with 6-O-sulfated CS also prominent in the IPM. There was labeling for DS throughout the retina and choroid, especially in the NFL, ganglion cell layer, and blood vessels. CONCLUSIONS. The detection of GAG chains with specific probes and fluorescence microscopy provides for the first time a detailed analysis of their compartmentalization in the human retina, by both GAG chain type and sulfation pattern. This reference map provides a basis for understanding the functional regulation of GAG-binding proteins in health and disease processes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21746802      PMCID: PMC3175996          DOI: 10.1167/iovs.11-7909

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  45 in total

Review 1.  Order out of chaos: assembly of ligand binding sites in heparan sulfate.

Authors:  Jeffrey D Esko; Scott B Selleck
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

Review 2.  Hyaluronan: from extracellular glue to pericellular cue.

Authors:  Bryan P Toole
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

3.  A CNS specific proteoglycan associated with astrocytes in rat optic nerve.

Authors:  E E Geisert; R C Williams; D J Bidanset
Journal:  Brain Res       Date:  1992-01-31       Impact factor: 3.252

4.  Occurrence of collagen and proteoglycan forms of type IX collagen in chick embryo cartilage. Production and characterization of a collagen form-specific antibody.

Authors:  T Yada; M Arai; S Suzuki; K Kimata
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

Review 5.  Production and characterization of monoclonal antibodies directed against connective tissue proteoglycans.

Authors:  B Caterson; J E Christner; J R Baker; J R Couchman
Journal:  Fed Proc       Date:  1985-02

6.  Vascular localization of heparan sulfate proteoglycans in retinas of patients with diabetes mellitus and in VEGF-induced retinopathy using domain-specific antibodies.

Authors:  A N Witmer; J van den Born; G F Vrensen; R O Schlingemann
Journal:  Curr Eye Res       Date:  2001-03       Impact factor: 2.424

Review 7.  Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting.

Authors:  Achilleas D Theocharis; Spyridon S Skandalis; George N Tzanakakis; Nikos K Karamanos
Journal:  FEBS J       Date:  2010-08-31       Impact factor: 5.542

8.  Action pattern of polysaccharide lyases on glycosaminoglycans.

Authors:  K A Jandik; K Gu; R J Linhardt
Journal:  Glycobiology       Date:  1994-06       Impact factor: 4.313

9.  Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

Authors:  Sindhulakshmi Kurup; Tessa J M Wijnhoven; Guido J Jenniskens; Koji Kimata; Hiroko Habuchi; Jin-Ping Li; Ulf Lindahl; Toin H van Kuppevelt; Dorothe Spillmann
Journal:  J Biol Chem       Date:  2007-05-21       Impact factor: 5.157

10.  Essential alterations of heparan sulfate during the differentiation of embryonic stem cells to Sox1-enhanced green fluorescent protein-expressing neural progenitor cells.

Authors:  Claire E Johnson; Brett E Crawford; Marios Stavridis; Gerdy Ten Dam; Annie L Wat; Graham Rushton; Christopher M Ward; Valerie Wilson; Toin H van Kuppevelt; Jeffrey D Esko; Austin Smith; John T Gallagher; Catherine L R Merry
Journal:  Stem Cells       Date:  2007-04-26       Impact factor: 6.277

View more
  34 in total

Review 1.  Role of heparan sulfate in ocular diseases.

Authors:  Paul J Park; Deepak Shukla
Journal:  Exp Eye Res       Date:  2013-02-11       Impact factor: 3.467

2.  Development of High-Resolution Three-Dimensional-Printed Extracellular Matrix Scaffolds and Their Compatibility with Pluripotent Stem Cells and Early Retinal Cells.

Authors:  Arwin Shrestha; Brittany N Allen; Luke A Wiley; Budd A Tucker; Kristan S Worthington
Journal:  J Ocul Pharmacol Ther       Date:  2019-08-16       Impact factor: 2.671

Review 3.  Glycosaminoglycan remodeling during diabetes and the role of dietary factors in their modulation.

Authors:  Vemana Gowd; Abhignan Gurukar; Nandini D Chilkunda
Journal:  World J Diabetes       Date:  2016-02-25

4.  Spectral domain optical coherence tomography imaging of mucopolysaccharidoses I, II, and VI A.

Authors:  Susie Seok; In Jeong Lyu; Kyung Ah Park; Sei Yeul Oh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-18       Impact factor: 3.117

Review 5.  Bioactive lipids and pathological retinal angiogenesis.

Authors:  Khaled Elmasry; Ahmed S Ibrahim; Samer Abdulmoneim; Mohamed Al-Shabrawey
Journal:  Br J Pharmacol       Date:  2018-11-19       Impact factor: 8.739

6.  Scleral permeability varies by mouse strain and is decreased by chronic experimental glaucoma.

Authors:  Mary E Pease; Ericka N Oglesby; Elizabeth Cone-Kimball; Joan L Jefferys; Matthew R Steinhart; Anthony J Kim; Justin Hanes; Harry A Quigley
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-21       Impact factor: 4.799

Review 7.  Development of diagnostic and treatment strategies for glaucoma through understanding and modification of scleral and lamina cribrosa connective tissue.

Authors:  Harry A Quigley; Frances E Cone
Journal:  Cell Tissue Res       Date:  2013-03-28       Impact factor: 5.249

8.  Dasatinib inhibits peripapillary scleral myofibroblast differentiation.

Authors:  Amanda Chow; Liam McCrea; Elizabeth Kimball; Julie Schaub; Harry Quigley; Ian Pitha
Journal:  Exp Eye Res       Date:  2020-03-13       Impact factor: 3.467

9.  Proteoglycan IMPG2 Shapes the Interphotoreceptor Matrix and Modulates Vision.

Authors:  Ezequiel M Salido; Visvanathan Ramamurthy
Journal:  J Neurosci       Date:  2020-04-07       Impact factor: 6.167

10.  Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1.

Authors:  Louise A Johnson; Suneale Banerji; William Lawrance; Uzi Gileadi; Gennaro Prota; Kayla A Holder; Yaowaluck M Roshorm; Tomáš Hanke; Vincenzo Cerundolo; Nicholas W Gale; David G Jackson
Journal:  Nat Immunol       Date:  2017-05-15       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.